Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Value in Health Regional Issues
|
April 29, 2018
The Role of the National Health Insurance Fund Administration in the Development of Health Economics and Health Technology Assessment in Hungary
Ferenc Oberfrank
Magyar Sebeszet
|
December 5, 2025
Ferenc Oberfrank, Tamás Freund
Orvosi Hetilap
|
November 10, 2015
[Applicability of hospital reports submitted for reimbursement purposes for epidemiological studies based on the example of ischemic cerebrovascular diseases]
András Ajtay, Ferenc Oberfrank, Dániel Bereczki
Acta Pharmaceutica Hungarica
|
July 5, 2013
[The influence of pharmacoeconomic laws on pharmacies between 2007-2010 in Hungary]
Imre Boncz, Verebes Eva Donkáné, Ferenc Oberfrank
Magyar Onkologia
|
December 18, 2010
[Assessment of annual health insurance reimbursement for oncology drugs in Hungary]
Imre Boncz, Eva Donkáné Verebes, Ferenc Oberfrank, et al.
Magyar Onkologia
|
March 31, 2010
[Health-economics of oncology care: changes in hospital bed capacity]
Imre Boncz, Eva Donka-Verebes, Ferenc Oberfrank, et al.
Magyar Onkologia
|
March 31, 2010
[Health economics of oncology care: financial effect of performance volume limit (PVL)]
Imre Boncz, Eva Donkáné Verebes, Ferenc Oberfrank, et al.
Ideggyogyaszati Szemle
|
December 2, 2020
[The connection between the socioeconomic status and stroke in Budapest]
Ildikó Vastagh, Ildikó Szőcs, Ferenc Oberfrank, et al.
Plos One
|
August 5, 2020
The prevalence of psychiatric symptoms before the diagnosis of Parkinson's disease in a nationwide cohort: A comparison to patients with cerebral infarction
Szabolcs Szatmári, András Ajtay, Ferenc Oberfrank, et al.
Geroscience
|
October 16, 2021
Cholinesterase inhibitors for the treatment of dementia: real-life data in Hungary
Nóra Balázs, Dániel Bereczki, András Ajtay, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Value in Health Regional Issues
|
April 29, 2018
The Role of the National Health Insurance Fund Administration in the Development of Health Economics and Health Technology Assessment in Hungary
Ferenc Oberfrank
Magyar Sebeszet
|
December 5, 2025
Ferenc Oberfrank, Tamás Freund
Orvosi Hetilap
|
November 10, 2015
[Applicability of hospital reports submitted for reimbursement purposes for epidemiological studies based on the example of ischemic cerebrovascular diseases]
András Ajtay, Ferenc Oberfrank, Dániel Bereczki
Acta Pharmaceutica Hungarica
|
July 5, 2013
[The influence of pharmacoeconomic laws on pharmacies between 2007-2010 in Hungary]
Imre Boncz, Verebes Eva Donkáné, Ferenc Oberfrank
Magyar Onkologia
|
December 18, 2010
[Assessment of annual health insurance reimbursement for oncology drugs in Hungary]
Imre Boncz, Eva Donkáné Verebes, Ferenc Oberfrank, et al.
Magyar Onkologia
|
March 31, 2010
[Health-economics of oncology care: changes in hospital bed capacity]
Imre Boncz, Eva Donka-Verebes, Ferenc Oberfrank, et al.
Magyar Onkologia
|
March 31, 2010
[Health economics of oncology care: financial effect of performance volume limit (PVL)]
Imre Boncz, Eva Donkáné Verebes, Ferenc Oberfrank, et al.
Ideggyogyaszati Szemle
|
December 2, 2020
[The connection between the socioeconomic status and stroke in Budapest]
Ildikó Vastagh, Ildikó Szőcs, Ferenc Oberfrank, et al.
Plos One
|
August 5, 2020
The prevalence of psychiatric symptoms before the diagnosis of Parkinson's disease in a nationwide cohort: A comparison to patients with cerebral infarction
Szabolcs Szatmári, András Ajtay, Ferenc Oberfrank, et al.
Geroscience
|
October 16, 2021
Cholinesterase inhibitors for the treatment of dementia: real-life data in Hungary
Nóra Balázs, Dániel Bereczki, András Ajtay, et al.
Page
of 2